{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-102447","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.454349+00:00","generated_at":"2026-05-17T20:44:06.039814+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Corbus Pharmaceuticals Q2 2025 Net Loss $17.7M, Pipeline on Track for Data Readouts H2 2025","bullets":["Net loss for Q2 2025 was $17.7 million ($1.44 per share), compared to $10.0 million loss in Q2 2024.","Cash and investments totaled $116.6 million as of June 30, 2025, expected to fund operations through Q2 2027.","Phase 1/2 dose expansion data for Nectin-4 ADC CRB-701 to be presented at ESMO 2025 in October.","Obesity drug CRB-913 initiated multiple ascending dose portion; SAD/MAD data expected later in 2025.","FDA granted Fast Track designation for CRB-701 in relapsed/refractory metastatic cervical cancer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-102447","json":"https://secwatch.observer/filing/0000950170-25-102447.json","markdown":"https://secwatch.observer/filing/0000950170-25-102447.md","text":"https://secwatch.observer/filing/0000950170-25-102447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025102447/0000950170-25-102447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025102447/crbp-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T20:44:06.039814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}